Comparison of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrent endometriosis
- Conditions
- Endometriosis.Endometriosis
- Registration Number
- IRCT20170917036227N5
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 130
Women aged 18-45 years old
Endometriosis confirmation via laparoscopy and histopathologic assessmnet
Pregnancy or Breast Feeding
Plan to become pregnant
Amenorrhea (no more menstruation - equal to 3 months in the last 6 months)
Undiagnosed genital bleeding
Recent use of hormonal agents
Contraindications to the use of progesterone
Having a risk factor for decreased bone density
Use of acitretin, anticoagulants such as warfarin, antidiabetic drugs, aperitif and, artemether, atazanavir, barbiturates, bexarotene, Boceprevir, bosentan, thrombogenic drugs, clobazam, anticonvulsant drugs (carphenazine, Topiramate, valproic acid, lamotrigine, phenytoin ...), Darunavir, Deferasirox, Efavirenz, Felbamate, Griseofulvin, Mifepristone, Nelfinavir, Neuruppin, Selegiline, Thalidomide, Tranexamic Acid and Voriconazole
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method